Medical devices comprising porous layers for the release of therapeutic agents

• US 20080051881A1
• Filed: 04/26/2007
• Published: 02/28/2008
• Est. Priority Date: 08/24/2006
• Status: Abandoned Application

• Current Assignee: Boston Scientific Scimed, Inc. (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed, Inc. (Boston Scientific Corporation)
• Inventors: Feng, James Q., Weber, Jan, Atanasoska, Liliana
• Application Number:
  US11/789,983
• Publication Number:
  US 20080051881A1
• Time in Patent Office: Days
• US Class Current: 623/1.39
• CPC Class Codes: A61L 17/06 At least partially resorbable materials
• CPC Class Codes: A61L 17/145 Coating
• CPC Class Codes: A61L 2300/416 Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
• CPC Class Codes: A61L 2300/604 Biodegradation
• CPC Class Codes: A61L 27/34 Macromolecular materials
• CPC Class Codes: A61L 27/54 Biologically active materials, e.g. therapeutic substances A61L27/227 takes precedence
• CPC Class Codes: A61L 27/56 Porous materials, e.g. foams or sponges
• CPC Class Codes: A61L 27/58 Materials at least partially resorbable by the body
• CPC Class Codes: A61L 29/085 Macromolecular materials
• CPC Class Codes: A61L 29/146 Porous materials, e.g. foams or sponges
• CPC Class Codes: A61L 29/148 Materials at least partially resorbable by the body
• CPC Class Codes: A61L 29/16 Biologically active materials, e.g. therapeutic substances A61L29/048 takes precedence
• CPC Class Codes: A61L 31/10 Macromolecular materials
• CPC Class Codes: A61L 31/146 Porous materials, e.g. foams or sponges
• CPC Class Codes: A61L 31/148 Materials at least partially resorbable by the body
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence

Abstract

In accordance with an aspect of the invention, implantable or insertable medical devices are provided in which a porous layer is disposed over a therapeutic-agent-containing region. In accordance with another aspect of the invention, medical devices are fabricated by a method in which a porous layer is deposited over a therapeutic-agent-containing region using a field-injection-based electrospray technique.

Claims

1. An implantable or insertable medical device comprising a substrate region, a porous layer disposed over said substrate region, a therapeutic agent disposed beneath said porous layer, and a biodegradable material disposed beneath said porous layer that regulates the release of said therapeutic agent from said medical device into a subject upon implantation or insertion of said device into said subject.

2. The medical device of claim 1, wherein said porous layer is biostable.

3. The medical device of claim 1, wherein said porous layer is a polymeric layer.

4. The medical device of claim 1, wherein said porous layer is a ceramic layer.

5. The medical device of claim 1, wherein said porous layer is a polymer-ceramic hybrid layer.

6. The medical device of claim 1, wherein said porous layer is a metallic layer.

7. The medical device of claim 1, wherein said porous layer is comprises fibers.

8. The medical device of claim 7, wherein said fibers are interconnected.

9. The medical device of claim 7, wherein fibers have diameters between 20 and 5000 nm.

10. The medical device of claim 1, wherein said porous layer comprises interconnected particles.

11. The medical device of claim 10, wherein said particles have diameters between 20 and 5000 nm.

12. The medical device of claim 1, wherein said porous layer is an electrostatically deposited layer.

13. The medical device of claim 1, wherein said porous layer is deposited using a field-injection-based electrospray technique.

14. The medical device of claim 1, wherein said substrate region is a polymeric substrate region.

15. The medical device of claim 1, wherein said substrate region is a ceramic substrate region.

16. The medical device of claim 1, wherein said substrate region is a metallic substrate region.

17. The medical device of claim 1, wherein said substrate region is a bioadverse substrate region.

18. The medical device of claim 1, wherein said substrate region is a biostable substrate region.

19. The medical device of claim 1, wherein said substrate region is a biodegradable substrate region.

20. The medical device of claim 1, wherein said substrate region comprises said therapeutic agent and said biodegradable material.

21. The medical device of claim 1, wherein said medical device comprises a therapeutic-agent-containing layer that comprises said therapeutic agent and said biodegradable material, and wherein said therapeutic-agent-containing layer is disposed between said substrate and said porous layer.

22. The medical device of claim 21, wherein said therapeutic-agent-containing layer is completely biodegradable.

23. The medical device of claim 21, wherein said therapeutic-agent-containing layer is partially biodegradable.

24. The medical device of claim 23, wherein said partially biodegradable therapeutic-agent-containing layer comprises a biostable porous portion and a therapeutic-agent-containing portion comprising said therapeutic agent and said biodegradable material disposed within the interstices of said biostable porous portion.

25. The medical device of claim 24, wherein said porous layer is biodegradable.

26. The medical device of claim 1, wherein said medical device comprises a therapeutic-agent-containing layer comprising said therapeutic agent disposed over said substrate, wherein said medical device comprises a biodegradable layer comprising said biodegradable material disposed over said therapeutic-agent-containing layer, and wherein said porous layer is disposed over said biodegradable layer.

27. The medical device of claim 26, wherein said biodegradable material is a biodegradable polymer.

28. The medical device of claim 1, wherein said porous region surrounds said substrate region, said therapeutic agent, and said biodegradable material.

29. The medical device of claim 1, wherein said substrate region has inner and outer surfaces and wherein said porous layer is disposed over one or both of said surfaces.

30. The medical device of claim 1, wherein said substrate region has inner and outer surfaces, wherein a first porous layer is disposed over said inner surface, and wherein a second porous layer is disposed over said outer surface, wherein said first and second porous layers may be formed from the same or different materials.

31. The medical device of claim 30, comprising (a) a first therapeutic agent and a first biodegradable material between said first porous layer and said inner surface, and (b) a second therapeutic agent and a second biodegradable material between said second porous layer and said outer surface, wherein said first and second therapeutic agents may the same or different and wherein said first and second biodegradable materials may be the same or different.

33. The medical device of claim 1, further comprising an additional therapeutic agent.

34. The medical device of claim 33, wherein said additional therapeutic agent is disposed within said porous layer.

35. The medical device of claim 1, wherein said therapeutic agent is selected from paclitaxel, paclitaxel-polymer conjugates, everolimus, everolimus-polymer conjugates, and combinations thereof.

32. A method of forming a medical device comprising depositing a porous layer over a therapeutic-agent-containing region using a field-injection-based electrospray technique.